Investors

Webcast ImageWebcast
Ocular Therapeutix, Inc. at the Piper Jaffray 28th Annual Healthcare Conference (Replay)
11/30/16 at 3:30 p.m. ET
Ocular Therapeutix, Inc. at the Piper Jaffray 28th Annual Healthcare Conference
Wednesday, November 30, 2016 3:30 p.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Webcast ImageWebcast
DEXTENZA Phase 3c Results Conference Call (Replay)
11/14/16 at 8:30 a.m. ET
DEXTENZA Phase 3c Results Conference Call
Monday, November 14, 2016 8:30 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Corporate Profile

Founded in 2006, Ocular Therapeutix is a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye.

The foundation of Ocular Therapeutix's pipeline is based on its proprietary, bioresorbable hydrogel technology that uses polyethylene glycol, or PEG, as a key component. The most advanced product candidate, currently in Phase 3 clinical development, is a drug-eluting intracanalicular depot containing the ste... More >>

Stock QuoteMore >>
OCUL (Common Stock)
ExchangeNASDAQ (US Dollar)
Price$9.37
Change (%) Stock is Down 0.15 (1.58%)
Volume132,150
Data as of 12/07/16 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
 
Investor EventsMore >>
There are currently no events scheduled.
Industry EventsMore >>
There are currently no events scheduled.
Receive E-mail Alerts
Sign up to receive e-mail alerts whenever Ocular Therapeutix, Inc. posts new information to the site.
Just enter your e-mail address and click Submit.
 
Data provided by Nasdaq. Minimum 15 minutes delayed.